FLU
MCID: INF038
MIFTS: 72

Influenza (FLU) malady

Categories: Infectious diseases, Genetic diseases

Aliases & Classifications for Influenza

Aliases & Descriptions for Influenza:

Name: Influenza 12 29 52 3 3 14 69
Flu 12 41 3
Influenza with Non-Respiratory Manifestation 12
Influenza with Other Manifestations Nos 12
Influenza with Other Manifestations 12
Influenza, Human 42

Classifications:



External Ids:

Disease Ontology 12 DOID:8469
ICD10 33 J11.1
ICD9CM 35 487
MeSH 42 D007251
NCIt 47 C53482
UMLS 69 C0021400

Summaries for Influenza

MedlinePlus : 41 flu is a respiratory infection caused by a number of viruses. the viruses pass through the air and enter your body through your nose or mouth. between 5% and 20% of people in the u.s. get the flu each year. the flu can be serious or even deadly for elderly people, newborn babies, and people with certain chronic illnesses. symptoms of the flu come on suddenly and are worse than those of the common cold. they may include body or muscle aches chills cough fever headache sore throat is it a cold or the flu? colds rarely cause a fever or headaches. flu almost never causes an upset stomach. and "stomach flu" isn't really flu at all, but gastroenteritis. most people with the flu recover on their own without medical care. people with mild cases of the flu should stay home and avoid contact with others, except to get medical care. if you get the flu, your health care provider may prescribe medicine to help your body fight the infection and lessen symptoms. the main way to keep from getting the flu is to get a yearly flu vaccine. good hygiene, including hand washing, can also help. nih: national institute of allergy and infectious diseases

MalaCards based summary : Influenza, also known as flu, is related to hepatitis c virus and swine influenza, and has symptoms including chills, fever and sore throat. An important gene associated with Influenza is IVNS1ABP (Influenza Virus NS1A Binding Protein), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Tequin and Norepinephrine have been mentioned in the context of this disorder. Affiliated tissues include t cells, lung and heart, and related phenotypes are Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers and Decreased influenza A H1N1 (A/WSN/33) virus numbers

CDC : 3 The 2016-2017 influenza season has peaked and flu activity continues to decline in the United States.

Disease Ontology : 12 A viral infectious disease that results_in infection, located in respiratory tract, has material basis in Influenzavirus A, has material basis in Influenzavirus B, or has material basis in Influenzavirus C, which are transmitted_by droplet spread of oronasal secretions during coughing, sneezing, or talking from an infected person. It is a highly contagious disease that affects birds and mammals and has symptom chills, has symptom fever, has symptom sore throat, has symptom runny nose, has symptom muscle pains, has symptom severe headache, has symptom cough, and has symptom weakness.

Wikipedia : 71 Influenza, commonly known as \"the flu\", is an infectious disease caused by an influenza virus.... more...

Related Diseases for Influenza

Diseases in the Influenza family:

Influenza, Severe

Diseases related to Influenza via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 436)
id Related Disease Score Top Affiliating Genes
1 hepatitis c virus 29.0 DDX58 IFITM1 IFITM3 IFNA1 MX1 RSAD2
2 swine influenza 12.5
3 avian influenza 12.5
4 haemophilus influenzae 12.3
5 influenza, severe 11.8
6 viral pneumonia 11.3
7 acute necrotizing encephalopathy 11.1
8 epiglottitis 11.1
9 common cold 11.0
10 lung disease 11.0
11 croup 11.0
12 acute diarrhea 11.0
13 haemophilus meningitis 10.9
14 encephalopathy, acute, infection-induced, 4 10.8
15 immunodeficiency 39 10.7
16 c3 deficiency 10.7
17 pontiac fever 10.7
18 selective igm deficiency disease 10.7
19 haverhill fever 10.7
20 gastroenteritis 10.7
21 white matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome 10.7
22 bronchitis 10.5
23 bronchopneumonia 10.5
24 pneumonia 10.4
25 anaerobic pneumonia 10.3
26 methylmalonic aciduria and homocystinuria, cblj type 10.3 IFNA1 ISG15 MX1
27 central nervous system angiosarcoma 10.3 DDX58 FURIN IFNA1
28 tetanus 10.3
29 senile cataract 10.2 DDX58 IFITM3 IFNA1 RSAD2
30 exophthalmos 10.2 DDX58 IFNA1 IFNG MX1
31 hyperimmunoglobulin syndrome 10.2 IFNA1 IFNG TMPRSS2
32 ornithosis 10.2
33 pertussis 10.2
34 gastroduodenitis 10.2 DDX58 IFNA1 IFNG
35 diphtheria 10.2
36 fungal gastritis 10.2 IFNA1 IFNG MX1
37 newcastle disease 10.1
38 hepatitis 10.1
39 meningitis 10.1
40 neonatal jaundice 10.1 IFNA1 IFNG MX1
41 hepatitis b 10.1
42 diabetes mellitus, insulin-dependent, 22 10.1 DDX58 IFITM1 IFNG RSAD2
43 otitis media 10.0
44 egg allergy 10.0
45 vaccinia 10.0
46 myocarditis 10.0
47 narcolepsy 9.9
48 encephalopathy 9.9
49 respiratory failure 9.9
50 acute disseminated encephalomyelitis 9.9

Graphical network of the top 20 diseases related to Influenza:



Diseases related to Influenza

Symptoms & Phenotypes for Influenza

Symptoms:

12
  • chills
  • fever
  • sore throat
  • runny nose
  • muscle pains
  • severe headache
  • cough
  • weakness

UMLS symptoms related to Influenza:


coughing, fever, pruritus, snoring, influenza-like symptoms, fever, catarrhal, acute, symptoms

GenomeRNAi Phenotypes related to Influenza according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers GR00195-A-3 9.46 IL1A ISG15 NXF1 XPO1
2 Decreased influenza A H1N1 (A/WSN/33) virus numbers GR00195-A-2 9.13 ISG15 NXF1 XPO1
3 Decreased influenza A/WSN/33 replication GR00195-A-1 8.92 NXF1 XPO1 IL1A ISG15

Drugs & Therapeutics for Influenza

FDA approved drugs:

id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Tequin 17 Bristol-Myers Squibb December, 1999

Drugs for Influenza (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 788)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Norepinephrine Approved Phase 4 51-41-2 439260
2
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2 147-94-4 6253
3
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
4
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Phase 1 103-90-2 1983
5
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1 75614-87-8, 51-45-6 774
6
Phenylephrine Approved Phase 4,Phase 3,Phase 1 59-42-7 6041
7
4-Aminopyridine Approved Phase 4,Phase 2 504-24-5 1727
8
Oxymetazoline Approved Phase 4,Phase 3,Phase 1 1491-59-4 4636
9
Ephedrine Approved Phase 4,Phase 3,Phase 1 299-42-3 9294
10
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
11
Calcium carbonate Approved Phase 4,Phase 3,Phase 1 471-34-1
12
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1 204255-11-8, 196618-13-0 65028
13
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 26787-78-0 33613 2171
14
Reboxetine Approved, Investigational Phase 4 98769-81-4, 71620-89-8 123628 65856
15
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
16
Pseudoephedrine Approved Phase 4,Phase 3,Phase 1 90-82-4 7028
17
Guaifenesin Approved, Vet_approved Phase 4,Phase 3 93-14-1 3516
18
Ethanol Approved Phase 4,Phase 2,Phase 1 64-17-5 702
19
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 772 46507594
20
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
21
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 58-22-0 6013
22
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 1 50-28-2 5757 53477783
23
Etoposide Approved Phase 4,Phase 2,Phase 3 33419-42-0 36462
24
Probenecid Approved Phase 4,Phase 1 57-66-9 4911
25
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
26
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
27
Ibuprofen Approved Phase 4,Phase 3 15687-27-1 3672
28
Atenolol Approved Phase 4 29122-68-7 2249
29
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
30
Rasagiline Approved Phase 4 136236-51-6 3052776
31
Formaldehyde Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-00-0 712
32
Ribavirin Approved Phase 4,Phase 3,Phase 2,Phase 1 36791-04-5 37542
33
Fluconazole Approved Phase 4,Phase 3,Phase 2 86386-73-4 3365
34
Adalimumab Approved Phase 4 331731-18-1 16219006
35
Ticlopidine Approved Phase 4 55142-85-3 5472
36
Azelastine Approved Phase 4,Phase 1 58581-89-8 2267
37
Abciximab Approved Phase 4 143653-53-6
38
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2 137-58-6 3676
39
Azithromycin Approved Phase 4,Phase 2 83905-01-5 55185 53477736 447043
40
Norgestimate Approved Phase 4,Phase 1 35189-28-7 6540478
41
Remifentanil Approved Phase 4 132875-61-7 60815
42
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
43
Sulfadiazine Approved, Vet_approved Phase 4 68-35-9 5215
44
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
45
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
46
Amantadine Approved Phase 4,Phase 2,Phase 1 768-94-5 2130
47
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 124-94-7 31307
48
Moxifloxacin Approved, Investigational Phase 4,Phase 1 354812-41-2, 151096-09-2 152946
49
Tizanidine Approved Phase 4 51322-75-9 5487
50
Acenocoumarol Approved Phase 4 152-72-7 9052 54676537

Interventional clinical trials:

(show top 50) (show all 3165)
id Name Status NCT ID Phase
1 The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Unknown status NCT02105519 Phase 4
2 Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. Unknown status NCT01063608 Phase 4
3 Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults Unknown status NCT01967368 Phase 4
4 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
5 A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold Unknown status NCT01651663 Phase 4
6 Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages Unknown status NCT01827462 Phase 4
7 Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults Unknown status NCT01811823 Phase 4
8 Influenza Vaccination in Patients With Scleroderma Unknown status NCT01002508 Phase 4
9 Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines Unknown status NCT01119157 Phase 4
10 Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients Unknown status NCT01512056 Phase 4
11 High Dose Influenza Vaccine in Nursing Home Unknown status NCT01720277 Phase 4
12 Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand Unknown status NCT01538940 Phase 4
13 Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis Unknown status NCT01002716 Phase 4
14 A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes Unknown status NCT01053377 Phase 4
15 Efficacy of Sambucol in the Treatment of Influenza Unknown status NCT00375115 Phase 4
16 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4
17 The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A Unknown status NCT01127282 Phase 4
18 Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years Unknown status NCT01289535 Phase 4
19 Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine Unknown status NCT01980836 Phase 4
20 Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients Unknown status NCT01017172 Phase 4
21 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
22 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4
23 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4
24 Enhancement of Motor Function With Reboxetine and Transcranial Direct Current Stimulation Unknown status NCT00853866 Phase 4
25 Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar® Unknown status NCT00828997 Phase 4
26 Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine Unknown status NCT00877357 Phase 4
27 Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS Unknown status NCT02259361 Phase 4
28 Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine Completed NCT02819115 Phase 4
29 Rapid Flu Tests in Travelers With Fever Completed NCT00821626 Phase 4
30 Inactivated Influenza Via Jet Injection Completed NCT02290691 Phase 4
31 Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting Completed NCT01654224 Phase 4
32 Direct and Indirect Protection by Influenza Vaccine Given to Children in India Completed NCT00934245 Phase 4
33 Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant. Completed NCT01808456 Phase 4
34 Maternal Flu Vaccine Trial in Bamako, Mali Completed NCT01430689 Phase 4
35 A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines Completed NCT01004653 Phase 4
36 Influenza Vaccine in HIV Infected Children Completed NCT00883012 Phase 4
37 The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine Completed NCT01736709 Phase 4
38 Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation) Completed NCT01691326 Phase 4
39 Hutterite Influenza Prevention Study Completed NCT00877396 Phase 4
40 A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years Completed NCT02212106 Phase 4
41 Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women Completed NCT01816464 Phase 4
42 Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home Completed NCT00812110 Phase 4
43 Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects Completed NCT01752881 Phase 4
44 Influenza Immunization of Children in India Completed NCT01680679 Phase 4
45 Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine Completed NCT01511744 Phase 4
46 Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants Completed NCT01047202 Phase 4
47 Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons Completed NCT01404182 Phase 4
48 Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military Completed NCT02640989 Phase 4
49 Vaccination Against Influenza in Autoimmune Diseases Completed NCT01065285 Phase 4
50 Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza Completed NCT01693380 Phase 4

Search NIH Clinical Center for Influenza

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: influenza, human

Genetic Tests for Influenza

Genetic tests related to Influenza:

id Genetic test Affiliating Genes
1 Influenza 29

Anatomical Context for Influenza

MalaCards organs/tissues related to Influenza:

39
T Cells, Lung, Heart, Testes, Neutrophil, Monocytes, Colon

The Foundational Model of Anatomy Ontology organs/tissues related to Influenza:

18
Respiratory Tract

Publications for Influenza

Articles related to Influenza:

(show top 50) (show all 4362)
id Title Authors Year
1
Impact of the 2014-2015 influenza season on the activity of an academic emergency department. ( 28091839 )
2017
2
Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs. ( 28057521 )
2017
3
Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins. ( 28079473 )
2017
4
Interstitial Pneumonia Associated with the Influenza Vaccine: A Report of Two Cases. ( 28090052 )
2017
5
Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine. ( 27881702 )
2017
6
Quantifying predictors for the spatial diffusion of avian influenza virus in China. ( 28086751 )
2017
7
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms. ( 27919896 )
2017
8
Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms. ( 27986898 )
2017
9
Fatal Progressive Membranous Obliterative Bronchitis: A Sequela of Influenza? ( 27984386 )
2017
10
Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany. ( 28522102 )
2017
11
Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation. ( 28054244 )
2017
12
Extracorporeal Life Support for severe respiratory failure with special reference to the influenza H1N1 pandemic. ( 28066903 )
2017
13
Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. ( 28062701 )
2017
14
Thyroid Storm Precipitated by Diabetic Ketoacidosis and Influenza A: A Case Report and Literature Review. ( 28090049 )
2017
15
Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction. ( 28169297 )
2017
16
OIE avian influenza portal. ( 28062760 )
2017
17
Resistance of non-typeable Haemophilus influenzae biofilms is independent of biofilm size. ( 27956464 )
2017
18
Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran. ( 28088246 )
2017
19
Experimental infection of mandarin duck with highly pathogenic avian influenza A (H5N8 and H5N1) viruses. ( 28062008 )
2017
20
Influenza A virus upregulates PRPF8 gene expression to increase virus production. ( 28110426 )
2017
21
Estimating Risks of Inapparent Avian Exposure for Human Infection: Avian Influenza Virus A (H7N9) in Zhejiang Province, China. ( 28054599 )
2017
22
Novel real-time PCR-based patho- and phylotyping of potentially zoonotic avian influenza A subtype H5 viruses at risk of incursion into Europe in 2017. ( 28084214 )
2017
23
Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review ( 28088130 )
2017
24
Immune history and influenza virus susceptibility. ( 28088686 )
2017
25
Novel variants of clade 2.3.2.1 H5N1 highly pathogenic avian influenza virus in migratory waterfowl of Hongze Lake. ( 28062014 )
2017
26
Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models. ( 28061848 )
2017
27
An M2-V27A channel blocker demonstrates potent inA vitro and inA vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. ( 28087313 )
2017
28
Seasonal vaccines - Critical path to pandemic influenza response. ( 28087149 )
2017
29
Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus. ( 28081672 )
2017
30
Single PA mutation as a high yield determinant of avian influenza vaccines. ( 28084423 )
2017
31
Proteome Response of Chicken Embryo Fibroblast Cells to Recombinant H5N1 Avian Influenza Viruses with Different Neuraminidase Stalk Lengths. ( 28079188 )
2017
32
Antisynthetase syndrome and influenza B, characteristic pulmonary involvement. ( 28063779 )
2017
33
IL-1I^ is a key cytokine that induces trypsin upregulation in the influenza virus-cytokine-trypsin cycle. ( 27714503 )
2017
34
Alveolar Macrophages Prevent Lethal Influenza Pneumonia By Inhibiting Infection Of Type-1 Alveolar Epithelial Cells. ( 28085958 )
2017
35
Genetic characterisation of novel, highly pathogenic avian influenza (HPAI) H5N6 viruses isolated in birds, South Korea, November 2016. ( 28079520 )
2017
36
Bacteremic renal stone-associated urinary tract infection caused by nontypable Haemophilus influenzae: A rare invasive disease in an immunocompetent patient. ( 27920983 )
2017
37
New real time and conventional RT-PCRs for updated molecular diagnosis of infectious bronchitis virus infection (IBV) in chickens in Egypt associated with frequent co-infections with avian influenza and Newcastle Disease viruses. ( 28336367 )
2017
38
Hidden authority study data have come to light: besides narcolepsy, the swine influenza vaccine Pandemrix caused type 1 diabetes. ( 27995691 )
2017
39
Haemophilus influenzae Serotype f Epiglottitis: A Case Report and Review. ( 28028010 )
2017
40
Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan. ( 27989625 )
2017
41
Vaccine efficacy of an inactivated, chimeric HA H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy. ( 28077631 )
2017
42
Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis. ( 28074789 )
2017
43
Antibody-dependent cellular cytotoxicity and influenza virus. ( 28088123 )
2017
44
Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro. ( 28085062 )
2017
45
Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain. ( 28077641 )
2017
46
Response to Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland. ( 28064237 )
2017
47
Henoch-SchAPnlein Purpura and Influenza Vaccine. ( 28065339 )
2017
48
H9N2 avian influenza virus enhances the immune responses of BMDCs by down-regulating miR29c. ( 28063705 )
2017
49
Haemophilus influenzae Type b Invasive Disease in Amish Children, Missouri, USA, 2014. ( 27983486 )
2017
50
Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial. ( 28089141 )
2017